Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-07
2000-09-05
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, A61K 3702, C07K 710, C07K 736
Patent
active
061143049
ABSTRACT:
Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
REFERENCES:
patent: 5124314 (1992-06-01), Cooper
patent: 5175145 (1992-12-01), Cooper
patent: 5187154 (1993-02-01), Phillips et al.
patent: 5234906 (1993-08-01), Young et al.
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5266561 (1993-11-01), Cooper et al.
patent: 5281581 (1994-01-01), Cooper et al.
patent: 5367052 (1994-11-01), Cooper et al.
patent: 5580953 (1996-12-01), Albrecht et al.
patent: 5686411 (1997-11-01), Gaeta et al.
Jonderko, Gut, vol. 30, pp. 430-5, 1989.
Embase Abstract No. 87177172 to Surg. Clin. North Amer. vol. 67/3 pp. 509-20, 1987.
Alam, et al., "Selective Angatonism Of Calcitonin-Induced Osteoclastic Quiescence (Q Effect) By Human Calcitonin Gene-Related Peptide-(Val.sup.8 Phe.sup.37)," Biochem. Biophys. Res. Commun., 179(1):134-139 (1991).
Amara, et al., "Expression in Brain of a Messenger RNA Encoding a Novel Neuropeptide Homologous to Calcitonin Gene-Related Peptide," Science, 229:1094-1097 (1985).
Brian, et al., "Amylin Amide, Which Is Structurally Similar To Calcitonin Gene-Related Peptide (Cgrp), Stimulates Increased Blood Flow In Vivo," Eur. J. Pharmacol., 183:2221 (1990).
Brener, et al., "Regulation of the Gastric Emptying of Glucose," Gastroenterology 85:76-82 (1983).
Briner, et al., "Tageszeitliche Schwankungen der Glukosetoleranz bei Diabetikern und Nichtdiabetikern, unter besonderer Berucksichtigung der Mangenentleerug," Schweiz Rundsh Med Prax 68:1666-1672 (1979).
Broderick, et al., Human and Rat Amylin have no effects on Insulin Secretion in Isolated Rat Pancreatic Islets, Biochem. Biophys. Res. Comm., vol. 177:932-938 (1991).
Camilleri & Malagelada, "Abnormal Intestinal Motility In Diabetics With the Gastroparesis Syndrome," Eur. J. Clin. Invest. 14:420-427 (1984).
Campbell, et al., "Gastric Emptying In Diabetic Autonomic Neuropathy," Gut 18:462-467 (1977).
Cavallo-Perin, et al., "Gastric Emptying Of Liquids And Solids Evaluated By Acetaminophen Test In Diabetic Patients With And Without Autonomic Neuropathy," Riv. Eur. Sci. Med. Farmacol., 13:205-209 (1991).
Chance, et al., Anorexia Following The Intrahypothalamic Administration Of Amylin, Brain Res., 539:352-354 (1991).
Chantry, et al., Cross-Reactivity Of Amylin With Calcitonin-Gene-Related Peptide Binding Sites In Rat Liver And Skeletal Muscle Membranes, Biochem. J., 277:139-143 (1991).
Clouse and Lustman, "Gastrointestinal Symptoms in Diabetic Patients," Proc. Natl. Acad. Sci., USA, 84:868-872 (1989).
Cooper, et al., Purification And Characterization Of A Peptide Form Amyloid-Rich Pancreases Of Type 2 Diabetic Patients, Proc. Natl. Acad. Sci., USA, 84:8628-8632 (1987).
Cooper, et al., "Amylin Found In Amyloid Deposits In Human Type 2 Diabetes Mellitus May Be A Hormone That Regulates Glycogen Metabolism In Skeletal Muscle," Proc. Natl. Acad. Sci., 85:7763-7766 (1988).
Cooper, et al., Amylin And The Amylin Gene: Structure, Function And Relationship To Islet Amyloid And To Diabetes Mellitus, Biochem. Biophys. Acta, 1014:247-258 (1989).
Cooper, et al., "The Amylin Superfamily: A Novel Grouping of Biologically Active Polypeptides Related to the Insulin A-Chain," Prog. Growth Factor Research 1:99-105 (1989).
Cooper, et al., "Amylin Action: Physiologic Bases And Pathologic Correlations," Diabetes, 497-500 (1991).
Cotroneo, et al., "Gastric Emptying Rate and Hormonal Response in Type II Diabetics," Diabetes Res. 17:99-104 (1991).
Daniel, et al., "Use of Glucagon in the Treatment of Acute Diverticultis," Br. Med. J., 3:720 (1974).
Dao, et al., "Lack of Modulation of Gastric Emptying by Acute Hyperglycemia in Type 2 Diabetes Mellitus," Gastroenterology 98:A32 (1990).
Deems, et al., "Amylin or CGRP (8-37) Fragments Reverse Amylin-Induced Inhibition of .sup.14 C-Glycogen Accumulation," Biochem. Biophys. Res. Comm., 181(1):116-120 (1991).
Eisenberg, et al., "Snychronous Gastric Motor And Secretory Activity In Normal And Diabetic Dogs: The Importance Of Variation In Blood Sugar Levels," Bulletin de la Societe Internationale de Chirurgie, 3:191-198 (1972).
Feldman, et al., "Abnormal Gastric Function in Longstanding, Insulin-Dependent Diabetic Patients," Gastroenterology 77:12-17 (1979).
Feldman, et al., "Disorders of Gastrointestinal Motility Associated with Diabetes Mellitus," Ann. Int. Med., 98:378-384 (1983).
Feldman, et al., "Gastric Emptying of Solid Radiopaque Markers: Studies in Healthy Subjects and Diabetic Patients," Gastroenterology, 87:895-902 (1984).
Follett, et al., "Effect of Amylin on Insulin receptor Kinase Activity In Vivo in the Rat," Clinical Research, 39(1):39A (1991).
Forster and Dockray, "Immunoneutralization suggests that calcitonin gene related peptide regulates gastric emptying in the rat," Neurosci. Lett., 131:5-7 (1991).
Franken, et al., "The Use of Glucagon in Hydrostatic Reduction of Intussusception: A Double-Blind Study of 30 Patients," Radiology, 146:687 (1983).
Fraser, et al., "Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus," Diabetologia, 33:675-680 (1990).
Fraser, et al., "Hyperglycaemia Stimulates Pyloric Motility In Normal Subjects," Gut, 32:475-478 (1991).
Faser, et al., "Effect Of Insulin-Induced Hypoglycaemia In Antral, Pyloric And Duodenal Motility In Fasting Subjects," Clin. Sci.,, 81:281-285 (1991).
Frontoni, et al., "In Vivo Insulin Resistance Induced by Amylin Primarily Through Inhibition of Insulin-Stimulated Glycogen Synthesis in Skeletal Muscle," Diabetes, 40:568-573 (1991).
Gaber, et al., "Changes in Gastric Emptying in recipients of Successful Combined Pancreas-Kidney Transplants," Dig. Dis., 9:437-443 (1991).
Galeazza, et al., "Islet Amyloid Polypeptide (IAPP) Competes for Two Binding Sites of CGRP," Peptides, 12:585-591 (1991).
Gardiner, et al., "Antagonistic Effect of Human .alpha.-Calcitonin Gene-related Peptide (8-37) on regional Hemodynamic Actions of Rat Islet Amyloid Polypeptide in Conscious Long-Evans Rats," Diabetes, 40:948-951 (1991).
Gedulin, et al., "Amylin Secretion from the Perfused Pancreas: Dissociation from Insulin and Abnormal Elevation in Insulin-Resistant Diabetic Rats," Biochem. Biophys. Res. Commun., 180(2):782-789 (1991).
Gilbey, et al., "Amylin Lowers Serum Calcium in Pagets Bond Disease Further Evidence for a Role in Calcium Metabolism," J. Bone Mineral Res., S293 (1991).
Gill, et al., "Effects of Ciglitazone on Endogenous Plasma Islet Amyloid Polypeptide and Insulin Sensitivity in Obese-Diabetic Viable Yellow Mice," Life Sciences, 48:703-710 (1991).
Glauser, et al., "Intravenous Glucagon in the Management of Esophageal Food Obstruction," J. Am. Coll. Emergency Physns., 8:228 (1979).
Gomez-Foix, et al., "Anti-Insulin Effects Of Amylin And Calcitonin-Gene-Related Peptide On Hepatic Glycogenmetabolism," Biochem. J., 276:607-610 (1991).
Goodman and Gilman's The Pharmacological Basis of Therapeutics, Chapter 38 (Pergamon Press, Eighth Edition 1990).
Hartter, et al., "Basal And Stimulated Plasma Levels Of Pancreatic Amylin Indicate Its Co-Secretion With Insulin In Humans," Diabetologia, 34:52-54 (1991).
Horowitz, et al., "Gastric And Oesophageal Emptying In Patients With Type 2 (Non-Insulin-Dependent) Diabetes Mellitus," Diabetologia, 32:151-159 (1989).
Horowitz, et al., "Disordered Gastric Motor Function in Diabetes Mellitus," Scand. J. Gastroenterol., 26:673-684 (1991).
Horowitz, et al., "Relationships Between Oesophageal Transit And Solid And Gastric Emptying In Diabetes Mellitus," Eur. J. Nucl. Med., 18:229-234 (1991).
Horowitz, et al., "Relationship Between Oral Glucose Tolerance And Gastric Emptying In Normal Healthy Subjects," Diabetologia, 36:857-862 (1993).
Horowitz, et al., Disordered Gastric Motor Function In Diabetes Mellitus, Diabetologia, 37:543-551 (1994).
Huang, et al., "Hype
Brown Kathleen Ann Keiting
Kolterman Orville G.
Rink Timothy J.
Young Andrew A.
Amylin Pharmaceuticals Inc.
Celsa Bennett
LandOfFree
Methods for regulating gastrointestinal motility does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for regulating gastrointestinal motility, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for regulating gastrointestinal motility will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212221